Results 91 to 100 of about 21,804,485 (185)
Enhancing the Solubility of BCS Class IV Antibiotics to Unleash Their Potential
Water solubility is a key physicochemical property during drug development, yet about 90% of new drug candidates exhibit low solubility. Numerous approaches have been proposed to enhance drug solubility, including physical modification and the use of ...
Agata Grzejdziak +3 more
doaj +1 more source
The biopharmaceutics classification system (BCS) and biopharmaceutics drug distribution classification system (BDDCS) are complementary classification systems that can improve, simplify, and accelerate drug discovery, development, and regulatory ...
Benet, Leslie, Larregieu, CA, Benet, LZ
core
Literature data on the properties of chloroquine phosphate, chloroquine sulfate, and chloroquine hydrochloride related to the Biopharmaceutics Classification System (BCS) are reviewed.
Barends, D M +9 more
core +1 more source
A science based approach to topical drug classification system (TCS). [PDF]
The Biopharmaceutics Classification System (BCS) for oral immediate release solid drug products has been very successful; its implementation in drug industry and regulatory approval has shown significant progress. This has been the case primarily because
Yacobi, A +4 more
core
Is the full potential of the biopharmaceutics classification system reached?
In this paper we analyse how the biopharmaceutics classification system (BCS) has been used to date. A survey of the literature resulted in a compilation of 242 compounds for which BCS classes were reported.
Andersson, Sara B. E., +4 more
core +1 more source
Biopharmaceutics classification system (BCS) as a framework for selective approach to bioavailability/bioequivalence (BA/BE) investigation [PDF]
One of fundamental investigations, that pharmaceutical industry is expected to conduct during development of pharmaceutical formulation in order to prove its efficiency and safety, is bioavailability (BA), or bioequivalence (BE) assessment. Traditional approach to this investigation entails strictly controlled, expensive and time consuming study in ...
Petronijević, Marija +3 more
openaire
Meeting report: International workshop on implementation of biowaivers based on the biopharmaceutics classification system (BCS) [PDF]
Even though the pivotal article stating the theoretical basis for a biopharmaceutics drug classification (1) was published almost 20 years ago, the extension of BCS-based biowaiver decisions to drugs belonging to BCS classes other than those showing high
Langguth, Peter +7 more
core
Background/Objectives: Despite the presumption of bioequivalence for BCS Class I drugs due to their high solubility and permeability, recent evidence indicates that those with rapid systemic elimination exhibit heightened vulnerability to Cmax non ...
Yan Lin +4 more
doaj +1 more source
The Biopharmaceutics Classification System (BCS) has facilitated biowaivers and played a significant role in enhancing drug regulation and development efficiency. However, the productivity of measuring the key discriminative properties of BCS, solubility and permeability, still requires improvement, limiting high-throughput applications of BCS, which ...
Zheng Wu +5 more
openaire +2 more sources
About 40% of approved drugs and nearly 90% of drug candidates have low aqueous solubility which limits their bioavailability resulting in suboptimal pharmacological activity. According to the Biopharmaceutical Classification System (BCS), drugs with low solubility and high permeability are categorized as BCS Class II, where the dissolution rate becomes
Zahra Noor Silmi Hermawan Ayodduki +4 more
openaire +1 more source

